Best of April: Top 5 Insights in Drug Formulation and Delivery

#1 - A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine

There are limitations to the currently available COVID-19 vaccines. An inhalable dry powder approach offers promising benefits, such as eliminating cold chain requirements, allowing for more widespread immunity.

#2 - Best Practices For Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

#3 - Navigating EU MDR Compliance: Overcoming Challenges To Sustain Your Certification

This article dispels the myth that obtaining EU MDR certification is an end point. The evolving landscape demands ongoing diligence to comprehend and adhere to changing requirements.

#4 - A Smart, Data-Driven Approach To Formulate Biotherapeutics For PFS With Confidence

Explore a unique model to predict injection force designed to decorrelate factors linked to formulation development and the ones linked to container and delivery device selection.

#5 - Breaking Through The Blood–Brain Barrier: The Rise Of Focused Ultrasound

Focused ultrasound can noninvasively, safely, and reversibly open the blood–brain barrier, overcoming a major obstacle for therapies targeting neurodegenerative diseases. Here's how.